BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15781865)

  • 21. Biallelic somatic inactivation of the mismatch repair gene MLH1 in a primary skin melanoma.
    Castiglia D; Pagani E; Alvino E; Vernole P; Marra G; Cannavò E; Jiricny J; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):165-75. PubMed ID: 12696065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
    Shin CY; Mellon I; Turker MS
    Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An intact Pms2 ATPase domain is not essential for male fertility.
    Fischer JM; Dudley S; Miller AJ; Liskay RM
    DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
    Baross-Francis A; Makhani N; Liskay RM; Jirik FR
    Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of DNA mismatch repair genes in naevi.
    Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
    In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of human mlh1 and pms2 ATPase activities to DNA mismatch repair.
    Tomer G; Buermeyer AB; Nguyen MM; Liskay RM
    J Biol Chem; 2002 Jun; 277(24):21801-9. PubMed ID: 11897781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.
    Ruschenburg I; Vollheim B; Stachura J; Cordon-Cardo C; Korabiowska M
    Anticancer Res; 2006; 26(3A):2107-12. PubMed ID: 16827152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
    Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
    Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
    Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
    Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.
    Marinovic-Terzic I; Yoshioka-Yamashita A; Shimodaira H; Avdievich E; Hunton IC; Kolodner RD; Edelmann W; Wang JY
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13993-8. PubMed ID: 18768816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression.
    Clendenning M; Macrae FA; Walsh MD; Walters RJ; Thibodeau SN; Gunawardena SR; Potter JD; Haile RW; Gallinger S; ; Hopper JL; Jenkins MA; Rosty C; Young JP; Buchanan DD
    Clin Genet; 2013 Jun; 83(6):591-3. PubMed ID: 23017166
    [No Abstract]   [Full Text] [Related]  

  • 35. Meiotic arrest and aneuploidy in MLH3-deficient mice.
    Lipkin SM; Moens PB; Wang V; Lenzi M; Shanmugarajah D; Gilgeous A; Thomas J; Cheng J; Touchman JW; Green ED; Schwartzberg P; Collins FS; Cohen PE
    Nat Genet; 2002 Aug; 31(4):385-90. PubMed ID: 12091911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice.
    Yao X; Buermeyer AB; Narayanan L; Tran D; Baker SM; Prolla TA; Glazer PM; Liskay RM; Arnheim N
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6850-5. PubMed ID: 10359802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
    Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S
    J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.